Loading…
Celerion accelerates drug development through world-class early phase clinical research and advanced bioanalysis services. With 50+ years of experience across 30 countries, the company conducts studies from preclinical through late-stage clinical phases to deliver fast, reliable data for confident decision-making.
AI named Celerion from December 2025 to June 2026.